164 related articles for article (PubMed ID: 10809946)
1. Acute axonal form of Guillain-Barré syndrome in a multiple sclerosis patient: chance association or linked disorders?
Capello E; Roccatagliata L; Schenone A; Gazzola P; Inglese M; Abbruzzese M; Mancardi GL
Eur J Neurol; 2000 Mar; 7(2):223-5. PubMed ID: 10809946
[TBL] [Abstract][Full Text] [Related]
2. Peripherin is a biomarker of axonal damage in peripheral nervous system disease.
Keddie S; Smyth D; Keh RYS; Chou MKL; Grant D; Surana S; Heslegrave A; Zetterberg H; Wieske L; Michael M; Eftimov F; Bellanti R; Rinaldi S; Hart MS; Petzold A; Lunn MP
Brain; 2023 Nov; 146(11):4562-4573. PubMed ID: 37435933
[TBL] [Abstract][Full Text] [Related]
3. Sural-sparing is seen in axonal as well as demyelinating forms of Guillain-Barré syndrome.
Umapathi T; Li Z; Verma K; Yuki N
Clin Neurophysiol; 2015 Dec; 126(12):2376-80. PubMed ID: 25743269
[TBL] [Abstract][Full Text] [Related]
4. Acute primary axonal Guillain-Barré syndrome.
Senanayake B; Fernando MA; Ranawaka UK; Gunasekara TG; Alibhoy AT; Wijesekara JC
Ceylon Med J; 2000 Mar; 45(1):36-8. PubMed ID: 11006620
[No Abstract] [Full Text] [Related]
5. Physiologic-pathologic correlation in Guillain-Barré syndrome in children.
Lu JL; Sheikh KA; Wu HS; Zhang J; Jiang ZF; Cornblath DR; McKhann GM; Asbury AK; Griffin JW; Ho TW
Neurology; 2000 Jan; 54(1):33-9. PubMed ID: 10636122
[TBL] [Abstract][Full Text] [Related]
6. Cyclo-oxygenases and prostaglandins in acute inflammatory demyelination of the peripheral nerve.
Hu W; Mathey E; Hartung HP; Kieseier BC
Neurology; 2003 Dec; 61(12):1774-9. PubMed ID: 14694045
[TBL] [Abstract][Full Text] [Related]
7. Immune Cell Profiling of the Cerebrospinal Fluid Provides Pathogenetic Insights Into Inflammatory Neuropathies.
Heming M; Schulte-Mecklenbeck A; Brix T; Wolbert J; Ruland T; Klotz L; Meuth SG; Gross CC; Wiendl H; Meyer Zu Hörste G
Front Immunol; 2019; 10():515. PubMed ID: 30984164
[No Abstract] [Full Text] [Related]
8. Relapsing demyelinating disease affecting both the central and peripheral nervous systems.
Zéphir H; Stojkovic T; Latour P; Lacour A; de Seze J; Outteryck O; Maurage CA; Monpeurt C; Chatelet P; Ovelacq E; Vermersch P
J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1032-9. PubMed ID: 18208860
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M
J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416
[TBL] [Abstract][Full Text] [Related]
10. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
[TBL] [Abstract][Full Text] [Related]
11. The sural sensory nerve is usually spared in Guillain-Barre syndrome.
Wee AS; Abernathy SD
J Miss State Med Assoc; 2003 Aug; 44(8):251-5. PubMed ID: 14531230
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
[TBL] [Abstract][Full Text] [Related]
13. Acute axonal idiopathic polyneuropathy: a Guillain-Barré syndrome variant?
Magi S; Sabatelli M; Mignogna T; Porcu C; Tonali P
Ital J Neurol Sci; 1992 Sep; 13(6):481-6. PubMed ID: 1428785
[TBL] [Abstract][Full Text] [Related]
14. Sural sparing in Guillain-Barré syndrome subtypes: a reappraisal with historical and recent definitions.
Hiew FL; Rajabally YA
Clin Neurophysiol; 2016 Feb; 127(2):1683-1688. PubMed ID: 26459671
[TBL] [Abstract][Full Text] [Related]
15. Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification.
Berciano J; Sedano MJ; Pelayo-Negro AL; García A; Orizaola P; Gallardo E; Lafarga M; Berciano MT; Jacobs BC
J Neurol; 2017 Feb; 264(2):221-236. PubMed ID: 27314967
[TBL] [Abstract][Full Text] [Related]
16. [Prognosis in Guillain-Barre syndrome assessed by clinical and neurophysiological features].
Smith TA
Ugeskr Laeger; 2000 Sep; 162(36):4805-7. PubMed ID: 10994378
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain-Barré syndrome.
Putzu GA; Figarella-Branger D; Bouvier-Labit C; Liprandi A; Bianco N; Pellissier JF
J Neurol Sci; 2000 Mar; 174(1):16-21. PubMed ID: 10704976
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases.
Griffin JW; Li CY; Ho TW; Xue P; Macko C; Gao CY; Yang C; Tian M; Mishu B; Cornblath DR
Brain; 1995 Jun; 118 ( Pt 3)():577-95. PubMed ID: 7600080
[TBL] [Abstract][Full Text] [Related]
19. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Pashenkov M; Jin JP; Link H
J Clin Immunol; 2003 Jul; 23(4):259-67. PubMed ID: 12959218
[TBL] [Abstract][Full Text] [Related]
20. [Clinically pure motor variant of Guillain-Barré polyneuritis. Report of 3 cases].
vd Ven C; Haupt WF; Rosenow F; Gibbels E; Borberg H
Nervenarzt; 1996 Dec; 67(12):1020-2. PubMed ID: 9082190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
